Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders -н Sato, D, Nakashima, I, Takahashi, T, Misu, T, Kuroda, H, Nishiyama, S, Waters, P, Fujihara, K

The Importance of Aquaporin-4 Antibody Assays in Patients beyond the Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders -н Sato, D, Nakashima, I, Takahashi, T, Misu, T, Waters, P, Kuroda, H, Nishiyama, S, Suzuki, C, Takai, Y, Itoyama, Y, Fujihara, K, Aoki, M

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. -н Sato, D, Nakashima, I, Takahashi, T, Misu, T, Waters, P, Kuroda, H, Nishiyama, S, Suzuki, C, Takai, Y, Fujihara, K, Itoyama, Y, Aoki, M

THE ASSOCIATION OF TWO RARE NEUROLOGICAL DISEASES: A MULTICENTRE STUDY OF 16 PATIENTS WITH ACHR ANTIBODY MYASTHENIA GRAVIS AND AQP4 ANTIBODY NEUROMYELITIS OPTICA SPECTRUM DISORDER -н Leite, M, Coutinho, E, Callegaro, D, Lana-Peixoto, M, Waters, P, Sato, D, Melamud, L, Graham, A, Vincent, A, Palace, J

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. -н Sato, D, Callegaro, D, Lana-Peixoto, M, Waters, P, de Haidar Jorge, F, Takahashi, T, Nakashima, I, Apostolos-Pereira, S, Talim, N, Simm, R, Lino, A, Misu, T, Leite, M, Aoki, M, Fujihara, K

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease -н Waters, P, Woodhall, M, O'Connor, K, Reindl, M, Lang, B, Sato, D, Juryńczyk, M, Tackley, G, Rocha, J, Takahashi, T, Misu, T, Nakashima, I, Palace, J, Fujihara, K, Leite, M, Vincent, A

Prevalence and clinical characteristics of neuromyelitis optica spectrum disorders patients with myelin oligodendrocyte glycoprotein antibodies -н Sato, D, Jorge, F, Lana-Peixoto, M, Waters, P, Nakashima, I, Apostolos Pereira, S, Talim, N, Takahashi, T, Zago, P, Leite, M, Bosso, K, Simm, R, Misu, T, Aoki, M, Fujihara, K, Callegaro, D

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies. -н Kaneko, K, Sato, D, Nakashima, I, Nishiyama, S, Tanaka, S, Marignier, R, Hyun, J, Oliveira, L, Reindl, M, Seifert-Held, T, Sepulveda, M, Siritho, S, Waters, P, Kurosawa, K, Akaishi, T, Kuroda, H, Misu, T, Prayoonwiwat, N, Berger, T, Saiz, A, Kim, H, Nomura, K, Callegaro, D, Fujihara, K, Aoki, M

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. -н Leite, M, Coutinho, E, Lana-Peixoto, M, Apostolos, S, Waters, P, Sato, D, Melamud, L, Marta, M, Graham, A, Spillane, J, Villa, A, Callegaro, D, Santos, E, da Silva, A, Jarius, S, Howard, R, Nakashima, I, Giovannoni, G, Buckley, C, Hilton-Jones, D, Vincent, A, Palace, J

Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. -н Noor, A, Whibley, A, Marshall, C, Gianakopoulos, P, Piton, A, Carson, A, Orlic-Milacic, M, Lionel, A, Sato, D, Pinto, D, Drmic, I, Noakes, C, Senman, L, Zhang, X, Mo, R, Gauthier, J, Crosbie, J, Pagnamenta, A, Munson, J, Estes, A, Fiebig, A, Franke, A, Schreiber, S, Stewart, A, Roberts, R